ERBB2 and invasive breast carcinoma: The National Comprehensive Cancer Network guidelines recommend that Oncotype DX testing should be done in all low-grade invasive breast carcinomas which are hormonal receptors positive and HER2 neu negative; hence, Magee Equation may be an alternative method to stratify these low-grade invasive breast carcinomas [14].